Cyteir Therapeutics, Inc.
Stoneham, MA
Patents
RAD51-INHIBITOREN
EP3681884
SUBSTITUIERTE THIAZOL DERIVATIVE ALS RAD51 HEMMSTOFFE ZUR BEHANDLUNG VON KREBSERKRANKUNGEN, AUTOIMMUN- UND NEURODEGENERATIVEN ZUSTÄNDEN
EP3652159
Holder of 2 patents, 2 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.